Clinical trial · Observational
Prognosis of Inpatients Evaluated for Palliative Radiotherapy
Observational Study of Prognosis of Inpatients Evaluated for Palliative Radiotherapy
NCT02312791CI-TRIAL-00036525PROGRADcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Understanding patient's prognosis is of utmost importance to determine radiotherapy's indication and dose/ fractionation. The investigators plan to conduct an observational study of prognosis of inpatients evaluated for palliative radiotherapy at a large cancer hospital in Brazil.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Palliative Patients
- description
- Inpatients evaluated for palliative radiation therapy.
Primary outcomes (1)
- measure
- Overall Survival
- timeFrame
- 9 months
- description
- Overall Survival in the studied population
Secondary outcomes (5)
- measure
- Overall Survival in Each Indication of Palliative Radiotherapy
- timeFrame
- 3 months and 9 months
- description
- Overall Survival in Each Indication of Palliative Radiotherapy. The indication will be as follow: * spinal cord compression * brain metastases * tumor bleeding * tumoral mass * Oncologic Pain * Superior Vena Cava Syndrome/ Airway compression
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * All inpatients evaluated for palliative radiation therapy at ICESP (Instituto do Cancer do Estado de Sao Paulo) Exclusion Criteria: * Inpatients evaluated whose intent of treatment is curative * Patients who are unwilling to participate in the study or unwilling to sign informed consent
References
Publications (4)
- BACKGROUNDMorita T, Tsunoda J, Inoue S, Chihara S. The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer. 1999 May;7(3):128-33. doi: 10.1007/s005200050242. PMID 10335930
- BACKGROUNDChow E, Abdolell M, Panzarella T, Harris K, Bezjak A, Warde P, Tannock I. Predictive model for survival in patients with advanced cancer. J Clin Oncol. 2008 Dec 20;26(36):5863-9. doi: 10.1200/JCO.2008.17.1363. Epub 2008 Nov 17. PMID 19018082
- BACKGROUNDWeltman E, Salvajoli JV, Brandt RA, de Morais Hanriot R, Prisco FE, Cruz JC, de Oliveira Borges S, Lagatta M, Ballas Wajsbrot D. Radiosurgery for brain metastases: who may not benefit? Int J Radiat Oncol Biol Phys. 2001 Dec 1;51(5):1320-7. doi: 10.1016/s0360-3016(01)01696-0. PMID 11728693
- DERIVEDChen ATC, Mauro GP, Gabrielli F, Chaves CLG, Castro I, Vasconcelos KM, Reis M, Saraiva T, Carvalho HA. PROGRAD - An observational study of the prognosis of inpatients evaluated for palliative radiotherapy. Radiother Oncol. 2018 May;127(2):299-303. doi: 10.1016/j.radonc.2018.03.021. Epub 2018 Apr 3. PMID 29625809